NCT04008329
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
Recruiting · Not specified · First Affiliated Hospital of Fujian Medical University · registry updated 2021-03-22
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.
Inclusion
- Amyotrophic Lateral Sclerosis patients fulfilling the El Escorial criteria (including definite, probable and possible)
- Progressive muscular atrophy
- Primary lateral sclerosis
- Progressive bulbar palsy
Exclusion
- History of serious head trauma or neuropsychiatric disease
- Decline to participate